← All indications
Tissue Adhesions
Pathological processes consisting of the union of the opposing surfaces of a wound.
Drugs by status
Approved for this indication (1)
Phase 4 trials (1)
Phase 3 trials (5)
Phase 2 trials (18)
- alg-1001
- paclitaxel
- fibrinogen (human)
- mitomycin
- platelet-rich plasma
- potassium chloride
- carboplatin
- allogeneic hematopoietic stem cells
- ceftriaxone
- bevacizumab
- sodium acetate
- collagenase clostridium histolyticum
- zinc dichloride
- tranexamic acid
- thrombin (human coagulation factor iia)
- exosomes from mesenchymal stem cells
- magnesium
- rp-l201
Organizations
Organization Involved with Phase 4 Indications (8)
Organization Involved with Phase 3 Indications (3)
Organization Involved with Phase 2 Indications (23)
- Allegro Ophthalmics, LLC
- Baxalta
- Chiesi
- Leading BioSciences, Inc
- Pergamum AB
- National Cancer Institute (NCI)
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute of Allergy and Infectious Diseases (NIAID)
- National Marrow Donor Program
- Karnataka Institute of Medical Sciences
- Medical College of Wisconsin
- University of Hull
- Capital Medical University
- Stony Brook University
- University of California, Los Angeles
- Uppsala University
- John and Rebecca Moore's Cancer Center
- Ludwig Maximilians University
- Blood and Marrow Transplant Clinical Trials Network
- Rocket Pharma Limited
- People's Liberation Army of China
- Orpha Labs
- Temple Therapeutics BV
Organization Involved with Phase 1 Indications (28)
- AdeTherapeutics Inc.
- AdvanceCor GmbH
- Mylan
- GlaxoSmithKline
- Mundipharma
- PharmaSurgics AB
- Huazhong University of Science and Technology
- Duke University
- Hospital Infantil Universitario Niño Jesús, Madrid, Spain
- Ophthalmic Consultants of Boston
- University of Miami
- University of Saskatchewan
- Zhejiang University
- Hebrew University
- AXIS Clinicals Limited
- TKL Research
- ABX-CRO
- Kendle International Inc.
- Berzelius Clinical Research Center
- Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China
- Kato Pharmaceuticals, Inc.
- Procorde GmbH
- Scilex Pharms Inc
- Chinese Academy of Medical Sciences
- Medherant Ltd
- Cooperative Clinical Drug Research and Development AG (CCDRD AG)
- PharmaNet (2006)
- Centinela Hospital Medical Center
Organization Involved with Other Experimental Indications (11)